This table summarizes the key evidence from recent clinical studies on the use of Dupilumab for CSU. It demonstrates findings across various study designs, from case reports to randomized controlled t
Supplementary data for the publication by Leducq S. et al. Efficacy and safety of methotrexate add-on therapy versus placebo for patients with chronic spontaneous urticaria resistant to H1-antihistami
Background: The role of Blastocystis spp. subtypes (STs) in chronic spontaneous urticaria (CSU) and the impact of the eradication are unclear. Objective: To investigate the role of Blastocystis spp. S
Chronic spontaneous urticaria (CSU) is a skin condition that significantly impairs quality of life. While omalizumab remains the standard treatment for patients who have failed antihistamines, emergin
